Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 24, 2004
Ethyl-EPA in Alzheimer's disease--a pilot studyPaul F Boston, Amanda Bennett, David F Horrobin, et al.Scandinavian Journal of Rheumatology|July 12, 2002
Gammalinolenic acid treatment of fatigue associated with primary Sjögren's syndromeElke Theander, David F Horrobin, Lennart T H Jacobsson, et al.Journal of Neurochemistry|September 24, 2004
Neuroprotective actions of eicosapentaenoic acid on lipopolysaccharide-induced dysfunction in rat hippocampusPeter E Lonergan, Darren S D Martin, David F Horrobin, et al.Blood|January 17, 2004
Cytosolic phospholipase A2 type IVA is present in human red cellsDonald J Macdonald, Rose M Boyle, Alastair C A Glen, et al.The Journal of Biological Chemistry|March 26, 2002
Neuroprotective effect of eicosapentaenoic acid in hippocampus of rats exposed to gamma-irradiationPeter E Lonergan, Darren S D Martin, David F Horrobin, et al.Prostaglandins, Leukotrienes, and Essential Fatty Acids|December 31, 2014
The development of an ELISA for group IVA phospholipase A2 in human red blood cellsDonald J Macdonald, Rose M Boyle, Alastair C A Glen, et al.Biological Psychiatry|January 7, 2003
Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patientsMeena Arvindakshan, Sandhya Sitasawad, Vijay Debsikdar, et al.The Journal of Biological Chemistry|July 2, 2002
Apoptotic changes in the aged brain are triggered by interleukin-1beta-induced activation of p38 and reversed by treatment with eicosapentaenoic acidDarren S D Martin, Peter E Lonergan, Barry Boland, et al.Neuroreport|April 2, 2002
MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatmentBasant K Puri, Graeme M Bydder, Serena J Counsell, et al.Pageof 2